|
Aug 29
|
Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
|
|
Jul 25
|
Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call
|
|
Jun 12
|
Insider Sale: Director Julie Mchugh Sells Shares of Ironwood Pharmaceuticals Inc (IRWD)
|
|
May 30
|
Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
|
|
May 12
|
US$16.33: That's What Analysts Think Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Is Worth After Its Latest Results
|
|
May 10
|
Ironwood Pharmaceuticals Reports Mixed Q1 2024 Results Amid Key Clinical Advancements
|
|
May 10
|
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript
|
|
May 10
|
Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
|
|
May 10
|
Ironwood Pharmaceuticals First Quarter 2024 Earnings: US$0.03 loss per share (vs US$0.30 profit in 1Q 2023)
|
|
May 9
|
Ironwood Pharmaceuticals Reports First Quarter 2024 Results
|
|
May 6
|
Ironwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference
|
|
May 2
|
Stonegate Healthcare Partners Updates Report on Transformative Therapies for Pruritus Management
|
|
May 2
|
Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q1 Earnings Expected to Decline
|
|
May 1
|
Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week® 2024
|
|
Apr 30
|
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Biotech Stocks
|
|
Apr 25
|
Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call
|
|
Mar 25
|
OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
|
|
Mar 5
|
It’s Time! 3 Failing Biotech Stocks to Sell Right Now
|
|
Feb 17
|
Ironwood Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations
|
|
Feb 16
|
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript
|